The energy of RSNA 2022 held late last month has really come back from pre-pandemic levels. With a robust expo floor, 40,000+ excited attendees, more than a hundred speakers, and over 330 courses, RSNA continues to be THE place where the science and tech of our industry come together with the radiologists and technicians who use it.
The Arterys team was in attendance, answering questions about AI-driven workflows and facilitating one of the sessions: Precision Oncology: Empowering Radiologists With AI-driven Workflow for Better Clinical Decisions in Cancer Patients. We agree with organizers and attendees that the quality of the science presented at RSNA was cutting-edge and reflected a strong focus on diagnosis and therapy.
Jorge Soto, MD, Chair of the RSNA Annual Meeting Program Planning Committee, noted that this particular year, RSNA had opened up a second call for abstracts to allow newer science and trials completed after the first spring deadline to be presented at the meeting. They selected 90 that were presented for the first time, with popular topics including:
- Photon-Counting CT
- Molecular Imaging
- Radiology Artificial Intelligence (AI)
Additionally, a few exciting abstracts were also presented on long-term COVID medical impacts and wellness issues, such as burnout, that impacted radiologists during the pandemic.
Photon-counting CT, which elevates temporal and spatial resolution, can improve image quality, decrease artifacts, and decrease radiation dose to patients. The technology was one of the top key trends presented at RSNA.
With targeted molecular imaging helping us move toward individualized patient care, PET systems are gaining momentum. Currently, molecular imaging is only conducted via PET systems, and in the last few years, patients with varying types of metastatic tumors who had no treatment options have been treated successfully by this advancing technology.
Now that the FDA has cleared several hundred AI algorithms and the initial stigma within the community is waning, many radiologists want to know how they can use the technology to help them. Many PACS vendors at the meeting demonstrated how they integrate with AI. And even vendors who do not use AI were capitalizing on the AI trend by using variations of the word "intelligence" on booths.
As Healthcare Innovation pointed out:
"As anyone who’s attended a healthcare conference with an exhibit floor knows, every year there tend to be one or two buzzwords or “buzz phrases” that seem to dominate the messaging in any particular year. And this year, it was “AI” and “intelligence”—when just three or four years ago, “VNA” was everywhere to be seen. Who can say what the buzzword or buzz phrase will be at RSNA23?"
Our RSNA presentation, Precision Oncology: Empowering Radiologists With AI-driven Workflow for Better Clinical Decisions in Cancer Patients, was delivered by Maya Khalifé, Arterys' Director of Product Management. Maya talked about how complex and fragmented the patient journey is and how traditional radiology workflows fail to keep up with the current demands on radiologists.
She then highlighted the AI-driven tools radiologists can access using Arterys, including:
- Longitudinal analysis
- Automated segmentation
- Automated lesion scoring
- Automated reporting
- A unified platform to share data that connects physicians
To dive deeper into our presentation, feel free to access Maya's slides. And we look forward to connecting with you at RSNA 2023!